Celleron Therapeutics Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
- Investors
-
1
Celleron Therapeutics General Information
Description
Operator of a biotechnology platform intended to provide clinical development of new therapies to treat cancer. The company's platform provides personalized medicines that are developed using a portfolio of technologies to develop a new class of mechanism-based cancer drugs, which will improve the success rates of treatment, enabling patients to effectively prevent cancer cell growth.
Contact Information
Website
www.cellerontherapeutics.comCorporate Office
- Magdalen Centre, Oxford Science Park
- Robert Robinson Avenue
- Oxford OX4 4GA
- England, United Kingdom
Corporate Office
- Magdalen Centre, Oxford Science Park
- Robert Robinson Avenue
- Oxford OX4 4GA
- England, United Kingdom
Celleron Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 05-Jan-2023 | Completed | Out of Business | |||
| 2. Later Stage VC | 31-Jan-2017 | Completed | Pre-Clinical Trials | |||
| 1. University Spin-Out | 24-Jun-2004 | Completed | Startup |
Celleron Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred Shares | ||||||||
| Preferred Shares | ||||||||
| Preferred Shares | ||||||||
| Ordinary | 27,833 | $0.001234 | $3.7 | $3.7 | 1x | $3.7 | 1.48% | |
| Ordinary | 176,471 | $0.001234 | $0.52 | $0.52 | 1x | $0.52 | 9.36% |
Celleron Therapeutics Comparisons
Industry
Financing
Details
Celleron Therapeutics Competitors (17)
One of Celleron Therapeutics’s 17 competitors is BPS Bioscience, a Corporation company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BPS Bioscience | Corporation | San Diego, CA | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Sygnature Discovery | Private Equity-Backed | Nottingham, United Kingdom | ||||
| Nuage Therapeutics | Venture Capital-Backed | Barcelona, Spain | ||||
| Autolus | Formerly VC-backed | London, United Kingdom |
Celleron Therapeutics Patents
Celleron Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4788332-A1 | Combination of cxd101 and an il-15 superagonist to treat proliferative diseases such as cancer | Pending | 03-Oct-2023 | ||
| WO-2025074090-A1 | Combination of cxd101 and an il-15 superagonist to treat proliferative diseases such as cancer | Inactive | 03-Oct-2023 | ||
| GB-202315149-D0 | Combination therapy | Inactive | 03-Oct-2023 | ||
| JP-2026536052-A | Proliferative disorders, for example, the combination of cxd101 and il-15 superagonist to treat cancer. | Pending | 03-Oct-2023 | ||
| EP-4313046-A1 | Vaccine adjuvant | Pending | 31-Mar-2021 | A61K31/454 |
Celleron Therapeutics Signals
Celleron Therapeutics Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DAOL Investment | PE/Buyout | Minority | ||
| IMM Investment | Asset Manager | Minority | ||
| Korea Investment Partners | Venture Capital | Minority | ||
| NHN Investment | Venture Capital | Minority | ||
| Oxford Spin-out Equity Management | Venture Capital | Minority |
Celleron Therapeutics FAQs
-
When was Celleron Therapeutics founded?
Celleron Therapeutics was founded in 2004.
-
Where is Celleron Therapeutics headquartered?
Celleron Therapeutics is headquartered in Oxford, United Kingdom.
-
What is the size of Celleron Therapeutics?
Celleron Therapeutics has 7 total employees.
-
What industry is Celleron Therapeutics in?
Celleron Therapeutics’s primary industry is Drug Discovery.
-
Is Celleron Therapeutics a private or public company?
Celleron Therapeutics is a Private company.
-
What is Celleron Therapeutics’s current revenue?
The current revenue for Celleron Therapeutics is .
-
How much funding has Celleron Therapeutics raised over time?
Celleron Therapeutics has raised $15.9M.
-
Who are Celleron Therapeutics’s investors?
DAOL Investment, IMM Investment, Korea Investment Partners, NHN Investment, and Oxford Spin-out Equity Management are 5 of 7 investors who have invested in Celleron Therapeutics.
-
Who are Celleron Therapeutics’s competitors?
BPS Bioscience, Adaptimmune Therapeutics, Sygnature Discovery, Nuage Therapeutics, and Autolus are some of the 17 competitors of Celleron Therapeutics.
-
When was Celleron Therapeutics acquired?
Celleron Therapeutics was acquired on 05-Jan-2023.
-
Who acquired Celleron Therapeutics?
Celleron Therapeutics was acquired by IngenOx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process